These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 36311688)
1. miR-20b-5p is a novel biomarker for detecting prostate cancer. Zhai TY; Dou M; Ma YB; Wang H; Liu F; Zhang LD; Chong T; Wang ZM; Xue L Oncol Lett; 2022 Dec; 24(6):426. PubMed ID: 36311688 [TBL] [Abstract][Full Text] [Related]
2. Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia. Ge Y; Wang Q; Shao W; Zhao Y; Shi Q; Yuan Q; Cui L J Cancer; 2020; 11(15):4542-4549. PubMed ID: 32489471 [No Abstract] [Full Text] [Related]
3. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role. Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-183-5p: A New Potential Marker for Prostate Cancer. Waseem M; Ahmad MK; Serajuddin M; Bhaskar V; Sankhwar SN; Mahdi AA Indian J Clin Biochem; 2019 Apr; 34(2):207-212. PubMed ID: 31092995 [TBL] [Abstract][Full Text] [Related]
5. MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia. Abramovic I; Vrhovec B; Skara L; Vrtaric A; Nikolac Gabaj N; Kulis T; Stimac G; Ljiljak D; Ruzic B; Kastelan Z; Kruslin B; Bulic-Jakus F; Ulamec M; Katusic-Bojanac A; Sincic N Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922968 [TBL] [Abstract][Full Text] [Related]
6. miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer. Qi JC; Yang Z; Zhang YP; Lu BS; Yin YW; Liu KL; Xue WY; Qu CB; Li W Front Oncol; 2019; 9():1535. PubMed ID: 32010624 [TBL] [Abstract][Full Text] [Related]
7. Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis. Jiang S; Chen H; He K; Wang J Bioengineered; 2022 Feb; 13(2):2004-2016. PubMed ID: 35030978 [TBL] [Abstract][Full Text] [Related]
8. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis. Barceló M; Castells M; Bassas L; Vigués F; Larriba S Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516 [TBL] [Abstract][Full Text] [Related]
9. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer. Pang C; Liu M; Fang W; Guo J; Zhang Z; Wu P; Zhang Y; Wang J Cell Physiol Biochem; 2016; 39(3):1111-7. PubMed ID: 27562849 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Peripheral Blood miR-374b-5p in Patients with Prostate Cancer. Pang C; Song X; Fu C; Zhang Y; Zhang Y; Liu M Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013356 [TBL] [Abstract][Full Text] [Related]
11. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone. Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843 [TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
13. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases. Dülgeroğlu Y; Eroğlu O Microrna; 2020; 9(4):303-309. PubMed ID: 33155933 [TBL] [Abstract][Full Text] [Related]
14. Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients. Li Z; Ma YY; Wang J; Zeng XF; Li R; Kang W; Hao XK Onco Targets Ther; 2016; 9():139-48. PubMed ID: 26770063 [TBL] [Abstract][Full Text] [Related]
15. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer. Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847 [TBL] [Abstract][Full Text] [Related]
17. Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification. Al-Kafaji G; Said HM; Alam MA; Al Naieb ZT Oncol Lett; 2018 Jul; 16(1):1357-1365. PubMed ID: 30061955 [TBL] [Abstract][Full Text] [Related]
18. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues. Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034 [TBL] [Abstract][Full Text] [Related]
19. Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy. Wang CB; Chen SH; Zhao L; Jin X; Chen X; Ji J; Mo ZN; Wang FB Clin Transl Oncol; 2023 Mar; 25(3):758-767. PubMed ID: 36266386 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer. Wang J; Ye H; Zhang D; Hu Y; Yu X; Wang L; Zuo C; Yu Y; Xu G; Liu S Cancer Cell Int; 2016; 16():12. PubMed ID: 26900347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]